Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies as of November 27, with notable gains for Aima Technology, Haier Biomedical, and Yaxiang Integration, showing increases of 57.48%, 36.35%, and 34.58% respectively [1][2] - A total of 13 target price adjustments were made by brokerages, with Aima Technology receiving the highest target price increase [1][2] - On November 27, 35 listed companies received brokerage recommendations, with companies like Zhongmu Co., West Securities, and GAC Group receiving one recommendation each [2] Group 2 - On the same date, 11 companies received initial coverage from brokerages, including GAC Group, which was rated "Buy" by Guotai Junan Securities [3][4] - Other companies receiving initial coverage include Haixi Communications, Yutong Technology, and Iwu Biological, all rated "Buy" or "Increase" by various brokerages [3][4] - The industries represented among the newly covered companies include passenger vehicles, automation equipment, packaging printing, and biological products [4]
35股获推荐,爱玛科技目标价涨幅超50%